WO2007097991A3 - Méthodes et trousses pour administrer des agents antiviraux - Google Patents

Méthodes et trousses pour administrer des agents antiviraux Download PDF

Info

Publication number
WO2007097991A3
WO2007097991A3 PCT/US2007/004003 US2007004003W WO2007097991A3 WO 2007097991 A3 WO2007097991 A3 WO 2007097991A3 US 2007004003 W US2007004003 W US 2007004003W WO 2007097991 A3 WO2007097991 A3 WO 2007097991A3
Authority
WO
WIPO (PCT)
Prior art keywords
dosing
methods
kits
antiviral agents
patient
Prior art date
Application number
PCT/US2007/004003
Other languages
English (en)
Other versions
WO2007097991A2 (fr
Inventor
Susan Erickson-Viitanen
Richard Steven Levy
Original Assignee
Pharmasset Inc
Susan Erickson-Viitanen
Richard Steven Levy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmasset Inc, Susan Erickson-Viitanen, Richard Steven Levy filed Critical Pharmasset Inc
Publication of WO2007097991A2 publication Critical patent/WO2007097991A2/fr
Publication of WO2007097991A3 publication Critical patent/WO2007097991A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention concerne des méthodes et des trousses de médicaments pour administrer de manière alternée à un patient des nucléosides antiviraux.
PCT/US2007/004003 2006-02-16 2007-02-15 Méthodes et trousses pour administrer des agents antiviraux WO2007097991A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US77399706P 2006-02-16 2006-02-16
US60/773,997 2006-02-16

Publications (2)

Publication Number Publication Date
WO2007097991A2 WO2007097991A2 (fr) 2007-08-30
WO2007097991A3 true WO2007097991A3 (fr) 2008-06-12

Family

ID=38437868

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2007/004003 WO2007097991A2 (fr) 2006-02-16 2007-02-15 Méthodes et trousses pour administrer des agents antiviraux

Country Status (1)

Country Link
WO (1) WO2007097991A2 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2268642E (pt) 2008-04-23 2015-06-02 Gilead Sciences Inc Análogos de carba-nulceósidos 1¿-substituídos para tratamento antiviral
WO2011035250A1 (fr) 2009-09-21 2011-03-24 Gilead Sciences, Inc. Procédés et intermédiaires pour préparer des analogues de carba-nucléoside 1'-substitués
KR101995598B1 (ko) 2010-07-19 2019-07-02 길리애드 사이언시즈, 인코포레이티드 부분입체 이성질성으로 순수한 포스포라미데이트 전구약물의 제조 방법
PL2595980T3 (pl) 2010-07-22 2015-03-31 Gilead Sciences Inc Sposoby i związki do leczenia infekcji wirusowych Paramyxoviridae
TWI687432B (zh) 2014-10-29 2020-03-11 美商基利科學股份有限公司 絲狀病毒科病毒感染之治療
ES2918585T3 (es) 2015-09-16 2022-07-19 Gilead Sciences Inc Métodos para el tratamiento de infecciones por el virus Arenaviridae
EP3595672B1 (fr) 2017-03-14 2023-09-06 Gilead Sciences, Inc. Composes a utiliser dans des méthodes de traitement d'infections par le coronavirus félin
ES2938859T3 (es) 2017-05-01 2023-04-17 Gilead Sciences Inc Una forma cristalina de (S)-2-etilbutilo 2-(((S)-(((2R,3S,4R,5R)-5-(4-aminopirrolo[2,1-f][1,2,4]triazin-7-il)-5-ciano-3,4-dihidroxitetrahidrofuran-2-il)metoxi)(fenoxi)fosforil)amino)propanoato
EP3651734A1 (fr) 2017-07-11 2020-05-20 Gilead Sciences, Inc. Compositions comprenant un inhibiteur d'arn polymérase et de la cyclodextrine pour le traitement d'infections virales
JP2023512656A (ja) 2020-01-27 2023-03-28 ギリアード サイエンシーズ， インコーポレイテッド ＳＡＲＳ ＣｏＶ－２感染を治療するための方法
TWI785528B (zh) 2020-03-12 2022-12-01 美商基利科學股份有限公司 1’-氰基核苷之製備方法
KR20220164784A (ko) 2020-04-06 2022-12-13 길리애드 사이언시즈, 인코포레이티드 1'-시아노 치환된 카르바뉴클레오시드 유사체의 흡입 제형
EP4157272A1 (fr) 2020-05-29 2023-04-05 Gilead Sciences, Inc. Méthodes de traitement par remdesivir
TWI819321B (zh) 2020-06-24 2023-10-21 美商基利科學股份有限公司 1'-氰基核苷類似物及其用途
TW202228722A (zh) 2020-08-27 2022-08-01 美商基利科學股份有限公司 用於治療病毒感染之化合物及方法
CN114010590B (zh) * 2021-11-24 2023-12-01 华东师范大学 一种核苷类抗病毒药物凝胶及其制备方法和应用
EP4320128A1 (fr) 2022-03-02 2024-02-14 Gilead Sciences, Inc. Composés et méthodes pour traiter des infections virales

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
PRUVOST ET AL.: "Measurement of Intracellular Didanosine...", ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, vol. 49, no. 5, 2005, pages 1907 - 1914 *
RAY ET AL.: "Role of Purine Nucleoside Phosphorylase Interactions between 2',3'-Dideoxyinosine and Allopurinol, Ganciclovir, or Tenofovir", ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, vol. 48, no. 4, 2004, pages 1089 - 1095, XP008037415, DOI: doi:10.1128/AAC.48.4.1089-1095.2004 *

Also Published As

Publication number Publication date
WO2007097991A2 (fr) 2007-08-30

Similar Documents

Publication Publication Date Title
WO2007097991A3 (fr) Méthodes et trousses pour administrer des agents antiviraux
EP2109814A4 (fr) Evaluation hybride d'expressions dans un système d'administration de base de données
ZA201000075B (en) Purin derivatives for use in the treatment of fab-related diseases
IL199151A (en) Pyrimidine derivatives, their pharmaceutical preparations, their use in cancer treatment and their kits
ZA200808022B (en) Inhibitors of human immunodeficiency virus replication
HK1153926A1 (en) Purin derivatives for use in the treatment of fab-related diseases fab-
IL195731A0 (en) Pyrimidine derivatives useful in the treatment of cancer
IL194865A (en) Amorophorins that are conserved in Heluaryl and their use
EP2069909A4 (fr) Stratégie pour fournir des résultats d'analyse sur la base d'une analyse de l'intention de l'utilisateur
WO2007100901A3 (fr) Schémas posologiques pour l'épinéphrine
EP1943507A4 (fr) Detecteur de nox et procedes d'utilisation associes
IL193604A (en) Use of human anti-22 @ il antibodies for @ preparation
IL195821A0 (en) Cycloalkanopyrrolocarbazole derivatives and the use thereof as parp, vegfr2 and mlk3 inhibitors
CA119744S (en) Bottle
IL193693A0 (en) Purine compounds and methods of use thereof
ZA200804688B (en) Purine derivatives and methods of use thereof
EP2084185A4 (fr) Anticorps humains neutralisant le métapneumovirus humain
ZA200809911B (en) Disposable article with serviceable indicia
EP1977691A4 (fr) Dispositif de mesure de composition corporelle permettant la reconnaissance des parties du corps utilisé dans le calcul des composants de la composition
CO6290689A2 (es) Derivados de 1,2,3,4-tetrahidropirrolo[1,2]pirazina-6-carboxamidas y de 2,3,4,5-tetrahidropirrol[1,2][1,4]-diazepina -7-carboxamidas su preparacion y su aplicacion en terapeutica
BRPI0714318A2 (pt) Utilização de 2-benzoil-imidazopiridinas em terapêutica
ZA201108106B (en) Use of phthalimide derivatives in the treatment of diseases
ZA200903865B (en) Pyrrole derivatives, preparation and use of the same in therapy
HK1124780A1 (en) Amidine derivatives and their uses as medicine
BRPI0719997A2 (pt) Uso de epotilonas no tratamento de osteoporose e doenças relacionadas

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 07750815

Country of ref document: EP

Kind code of ref document: A2